Astrana Corp - ASTH Enterprise Value to EBITDA Ratio
An aging population guarantees Astrana Health (ASTH) stable demand, shielding the business from market volatility. An asset-light model powered by an IT platform optimizes expenses, while a physician incentive system based on quality of care strengthens the team. The company's dynamic EV/EBITDA ratio clearly demonstrates the current market valuation, with this metric equaling 10.63, allowing for the tracking of operating profit efficiency.
Analytical breakdowns for astranahealth.com (ASTH)
- market price and analyst price targets:
- issuer market value details:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Astrana Health, Inc.|ASTH - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Astrana Health|ASTH - Aggregate Debt Obligations|Debts to Book Capitalization Astrana Corp|ASTH - Company Long-Term Debts|Company Short-Term Debt Astrana Health|Quick Ratio astranahealth.com
- financial results and valuation multiples details:
ASTH - Net Profit|Future Profit Astrana Health, Inc.|ASTH - Company Value to Net Income|Forward P/E Multiple Astrana Health, Inc.|ASTH - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Astrana Corp|ASTH - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Astrana Health|ASTH - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months astranahealth.com|ASTH - Earnings per share growth in current year|Expected earnings per share growth for next year Astrana Health, Inc.
Summary company analysis:Apollo Medical Holdings ASTH
The multiple compares the total enterprise value, including debt, to operating profit before depreciation and amortization, allowing the investor to assess cash flow generation efficiency relative to the market price. For Astrana Health, Inc. (ASTH), which optimizes expenses through AI analytics, the current EV/EBITDA valuation demonstrates how its technological advantage in healthcare converts into fundamental enterprise value and the stability of its financial model.
Competitors of Astrana Health, Inc.
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HCA Healthcare HCA|THC: Enterprise Value to Operating Income Before Depreciation|FMS: Enterprise Value to EBITDA Ratio|solventum.com - Enterprise Value to Operating Income Before Depreciation Ratio|EHC: EV/EBITDA Multiple|Universal Health Services, Inc. (UHS) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DaVita Inc|RadNet Management (RDNT) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio OPCH (Option Care Health)|Enterprise Value to Operating Income Before Depreciation Ratio SGRY|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Premier PINC|Business Value to Operating Income Before Depreciation EYE|Progyny Health - EV/EBITDA Multiple|ARDT - EV/EBITDA Multiple|Select Medical (SEM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation MD|USPH (US Physical Therapy) - EV/EBITDA Multiple|EV/EBITDA Multiple Pennant Group|Enterprise Value to EBITDA Ratio ORGO (Organogenesis Inc.)|NUTX (Nutex Health Hospitals) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUNA (Auna SA)|Business Value to Operating Income Before Depreciation SBC|Evolus - EV/EBITDA Multiple|Company Value to EBITDA CHS|SKIN: EV/EBITDA Multiple|MediWound (MDWD) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization biote Corp.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization JYNT|Enterprise Value to EBITDA Ratio DCGO (DocGo)|Enterprise Value to Operating Income Before Depreciation Ratio PIII|EV/EBITDA Multiple GANX (Gain Therapeutics, Inc.)|Business Value to Operating Income Before Depreciation EUDA|BMGL: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation CLGN (CollPlant Biotechnologies)|CUPR: EV/EBITDA Multiple|CCM - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization American Shared Hospital Services, Inc.|Enterprise Value to Operating Income Before Depreciation MRM (MEDIROM Corp)|EV/EBITDA Multiple ALBT|Enterprise Value to EBITDA Ratio dih.com DHAI|Carmell Therapeutics - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio NewGenIvf Group (NIVF)|ATI Physical Therapy Corp - EV/EBITDA Multiple|CMAX - EV/EBITDA Multiple|Kindly MD, Inc. (KDLY) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MODV - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio NVOS|SSY (SunLink Health Systems, Inc) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple BACK
